Jeffrey B. Kindler is a businessperson who founded Centrexion Therapeutics Corp. and who has been at the head of 7 different companies. Currently, Mr. Kindler holds the position of Chairman for GLG Healthcare Institute, Chief Executive Officer & Director at Centrexion Therapeutics Corp. and Venture Partner at Lux Capital Group LLC.

He is also Member of The U.S.-Japan Business Council, Inc. and Principal at Paragon Pharmaceuticals Capital LLC and on the board of 12 other companies.

Jeffrey B. Kindler previously held the position of Chairman & Chief Executive Officer at Pfizer Inc., Chairman of vTv Therapeutics, Inc., Partner at Williams & Connolly LLP, Director at Starboard Capital Partners LLC, Trustee at The Business Roundtable, Trustee at The Business Council, Editor at The Harvard Law Review Association, Principal at Marathon Pharmaceuticals LLC, Executive VP-Corporate Relations & General Counsel at McDonald's Corp. and President of Partner Brands (a subsidiary of McDonald's Corp.), Vice President-Litigation & Legal Policy at General Electric Co., Chairman for Boston Market Corp., Chairman at Pharmaceutical Research & Manufacturers of America, Trustee at Ronald McDonald House Charities Central West, Director at Lincoln Center for the Performing Arts, Inc. and Director at Manhattan Theatre Club, Inc.

He received an undergraduate degree from Tufts University and a graduate degree from Harvard Law School.